Prentice Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,451
Closed -$531K 107
2024
Q3
$531K Sell
8,451
-147
-2% -$8.58K 0.16% 75
2024
Q2
$508K Sell
8,598
-2,366
-22% -$148K 0.17% 74
2024
Q1
$874K Buy
10,964
+566
+5% +$43.2K 0.3% 45
2023
Q4
$821K Buy
10,398
+1,037
+11% +$73.8K 0.32% 40
2023
Q3
$654K Sell
9,361
-184
-2% -$13K 0.3% 44
2023
Q2
$660K Sell
9,545
-1,646
-15% -$117K 0.3% 39
2023
Q1
$832K Sell
11,191
-453
-4% -$38K 0.4% 33
2022
Q4
$1.09M Sell
11,644
-52
-0.4% -$5.02K 0.55% 23
2022
Q3
$1.11M Buy
+11,696
New +$1.16M 0.61% 20
2022
Q2
Sell
-11,219
Closed -$1.14M 152
2022
Q1
$1.14M Buy
11,219
+410
+4% +$43.1K 0.55% 25
2021
Q4
$1.11M Sell
10,809
-162
-1% -$15K 0.52% 23
2021
Q3
$931K Buy
10,971
+138
+1% +$11.6K 0.45% 25
2021
Q2
$904K Sell
10,833
-247
-2% -$20.2K 0.46% 22
2021
Q1
$834K Buy
+11,080
New +$807K 0.46% 23

Other funds holding CVS

Prentice Wealth Management's CVS Position: Q4 2024 in Review

Prentice Wealth Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 8,451 shares — an estimated $531K sold.

Prentice Wealth Management first reported a position in CVS in Q1 2021 and held it in 14 quarters. The position peaked at $1.14M in Q1 2022. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Prentice Wealth Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Prentice Wealth Management sold 8,451 CVS Health shares in Q4 2024, an estimated $531K.
  • Prentice Wealth Management first reported a position in CVS Health in Q1 2021 and held it in 14 quarters.
  • Prentice Wealth Management's CVS Health position peaked at $1.14M in Q1 2022.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Prentice Wealth Management's 13F filing for Q4 2024, filed 3 Feb 2025.